|
Video: What is a Stock Split?
|
|
DermTech is a molecular diagnostic company developing and marketing non-invasive genomics tests to aid in the diagnosis and management of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. Co.'s focus is skin cancer. Co. provides the DermTech Melanoma Test for the early detection of melanoma and is developing a product for non-melanoma skin cancer. Co. is also working on products to assess precancerous genomic changes associated with sun UV exposure to the skin. Co. has additional skin cancer product offerings, including for non-melanoma skin cancers (basal cell and squamous cell cancers), under development. According to our DMTK split history records, DermTech has had 1 split. | |
|
DermTech (DMTK) has 1 split in our DMTK split history database. The split for DMTK took place on August 30, 2019. This was a 1 for 2 reverse split, meaning for each 2 shares of DMTK owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 500 share position following the split.
When a company such as DermTech conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the DMTK split history from start to finish, an original position size of 1000 shares would have turned into 500 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into DermTech shares, starting with a $10,000 purchase of DMTK, presented on a split-history-adjusted basis factoring in the complete DMTK split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
08/11/2017 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$19.40 |
|
End price/share: |
$0.60 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-96.93% |
|
Average Annual Total Return: |
-40.53% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$307.25 |
|
Years: |
6.70 |
|
|
|
Date |
Ratio |
08/30/2019 | 1 for 2 |
|
|